Please wait a minute...
Protein & Cell

ISSN 1674-800X

ISSN 1674-8018(Online)

CN 11-5886/Q

Postal Subscription Code 80-984

2018 Impact Factor: 7.575

Protein Cell    2018, Vol. 9 Issue (2) : 196-206    https://doi.org/10.1007/s13238-017-0423-5
REVIEW
Structural and functional roles of ether lipids
John M. Dean, Irfan J. Lodhi()
Division of Endocrinology, Metabolism and Lipid Research, Department of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA
 Download: PDF(732 KB)  
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Ether lipids, such as plasmalogens, are peroxisomederived glycerophospholipids in which the hydrocarbon chain at the sn-1 position of the glycerol backbone is attached by an ether bond, as opposed to an ester bond in the more common diacyl phospholipids. This seemingly simple biochemical change has profound structural and functional implications. Notably, the tendency of ether lipids to form non-lamellar inverted hexagonal structures in model membranes suggests that they have a role in facilitating membrane fusion processes. Ether lipids are also important for the organization and stability of lipid raft microdomains, cholesterol-rich membrane regions involved in cellular signaling. In addition to their structural roles, a subset of ether lipids are thought to function as endogenous antioxidants, and emerging studies suggest that they are involved in cell differentiation and signaling pathways. Here, we review the biology of ether lipids and their potential significance in human disorders, including neurological diseases, cancer, and metabolic disorders.

Keywords ether lipids      plasmalogen      phospholipid      peroxisomes      cancer      metabolic disorders     
Corresponding Author(s): Irfan J. Lodhi   
Issue Date: 22 March 2018
 Cite this article:   
John M. Dean,Irfan J. Lodhi. Structural and functional roles of ether lipids[J]. Protein Cell, 2018, 9(2): 196-206.
 URL:  
https://academic.hep.com.cn/pac/EN/10.1007/s13238-017-0423-5
https://academic.hep.com.cn/pac/EN/Y2018/V9/I2/196
1 Albert DH, Anderson CE (1977) Ether-linked glycerolipids in human brain tumors . Lipids 12:188–192
https://doi.org/10.1007/BF02533292
2 Albert CJ, Thukkan AK, Heuertz RMet al. (2003) Eosinophil peroxidase-derived reactive brominating species target the vinyl ether bond of plasmalogens generating a novel chemoattractant, alpha-bromo fatty aldehyde . J Biol Chem 278:8942–8950.
https://doi.org/10.1074/jbc.M211634200
3 Alshehry ZH, Mundra PA, Barlow CKet al. (2016) Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus clinical perspective . Circulation 134:1637–1650.
https://doi.org/10.1161/CIRCULATION AHA.116.023233
4 Barøy T, Koster J, Strømme Pet al. (2015) A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform . Hum Mol Genet 24:5845–5854.
https://doi.org/10.1093/hmg/ddv305
5 Barr J, Caballería J, Martínez-Arranz Iet al. (2012) Obesitydependent metabolic signatures associated with nonalcoholic fatty liver disease progression . J Proteome Res 11:2521–2532.
https://doi.org/10.1021/pr201223p
6 Benjamin DI, Cozzo A, Ji Xet al. (2013) Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity . Proc Natl Acad Sci 110:14912–14917.
https://doi.org/10.1073/pnas.1310894110
7 Bräutigam C, Engelmann B, Reiss Det al. (1996) Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis . Atherosclerosis 119:77–88
https://doi.org/10.1016/0021-9150(95)05632-7
8 Braverman NE, Moser AB (2012) Functions of plasmalogen lipids in health and disease . Biochim Biophys Acta BBA Mol Basis Dis 1822:1442–1452.
https://doi.org/10.1016/j.bbadis.2012.05.008
9 Braverman N, Steel G, Obie Cet al. (1997) Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata . Nat Genet 15:369–376
https://doi.org/10.1038/ng0497-369
10 Braverman NE, Raymond GV, Rizzo WBet al. (2016) Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines . Mol Genet Metab 117:313–321.
https://doi.org/10.1016/j.ymgme. 2015.12.009
11 Brites P (2003) Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata . Hum Mol Genet 12:2255–2267.
https://doi.org/10.1093/hmg/ddg236
12 Brites P, Ferreira AS, Ferreira da Silva Tet al. (2011) Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice . PLoS ONE 6:e28539.
https://doi.org/10.1371/journal.pone. 0028539
13 Brodde A, Teigler A, Brugger Bet al. (2012) Impaired neurotransmission in ether lipid-deficient nerve terminals . Hum Mol Genet 21:2713–2724.
https://doi.org/10.1093/hmg/dds097
14 Broniec A, Klosinski R, Pawlak Aet al. (2011) Interactions of plasmalogens and their diacyl analogs with singlet oxygen in selected model systems . Free Radic Biol Med 50:892–898.
https://doi.org/10.1016/j.freeradbiomed.2011.01.002
15 Broniec A, Żądło A, Pawlak Aet al. (2017) Interaction of plasmenylcholine with free radicals in selected model systems . Free Radic Biol Med 106:368–378
https://doi.org/10.1016/j.freeradbiomed.2017.02.029
16 Buchert R, Tawamie H, Smith Cet al. (2014) A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency . Am J Hum Genet 95:602–610.
https://doi.org/10.1016/j.ajhg.2014.10.003
17 Cader MZ, Boroviak K, Zhang Qet al. (2016) C13orf31 (FAMIN) is a central regulator of immunometabolic function . Nat Immunol 17:1046–1056.
https://doi.org/10.1038/ni.3532
18 Chen X, Chen H, Dai Met al. (2016) Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions . Oncotarget 7:36622–36631
https://doi.org/10.18632/oncotarget.9124
19 da Silva TF, Sousa VF, Malheiro AR, Brites P (2012) The importance of ether-phospholipids: a view from the perspective of mouse models. Biochim Biophys Acta BBA Mol Basis Dis 1822:1501–1508.
https://doi.org/10.1016/j.bbadis.2012.05.014
20 da Silva TF, Eira J, Lopes ATet al. (2014) Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination . J Clin Investig 124:2560–2570.
https://doi.org/10.1172/JCI72063
21 Davies SS, Pontsler AV, Marathe GKet al. (2001) Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferatoractivated receptor ligands and agonists . J Biol Chem 276:16015–16023.
https://doi.org/10.1074/jbc.M100878200
22 Eisinger K, Krautbauer S, Hebel Tet al. (2014) Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes . Exp Mol Pathol 97:37–43.
https://doi.org/10.1016/j.yexmp.2014.05.002
23 Fabelo N, Martín V, Santpere Get al. (2011) Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson’s disease and incidental Parkinson’s disease . Mol Med 17:1107
https://doi.org/10.2119/molmed.2011.00119
24 Facciotti F, Ramanjaneyulu GS, Lepore Met al. (2012) Peroxisomederived lipids are self antigens that stimulate invariant natural killer T cells in the thymus . Nat Immunol 13:474–480.
https://doi.org/10.1038/ni.2245
25 Farooqui AA, Horrocks LA (2001) Book review: plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia . Neuroscientist 7:232–245
https://doi.org/10.1177/107385840100700308
26 Felder TK, Ring-Dimitriou S, Auer Set al. (2017) Specific circulating phospholipids, acylcarnitines, amino acids and biogenic amines are aerobic exercise markers . J Sci Med Sport.
https://doi.org/10.1016/j.jsams.2016.11.011
27 Fu S, Yang L, Li Pet al. (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity . Nature 473:528–531.
https://doi.org/10.1038/nature09968
28 Gibellini F, Smith TK (2010) The Kennedy pathway—de novo synthesis of phosphatidylethanolamine and phosphatidylcholine . IUBMB Life 62:414–428
https://doi.org/10.1002/iub.354
29 Ginsberg L, Rafique S, Xuereb JHet al. (1995) Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer’s disease brain . Brain Res 698:223–226
https://doi.org/10.1016/0006-8993(95)00931-F
30 Ginsberg L, Xuereb JH, Gershfeld NL (1998) Membrane instability, plasmalogen content, and Alzheimer’s disease . J Neurochem 70:2533–2538
https://doi.org/10.1046/j.1471-4159.1998.70062533.x
31 Glaser PE, Gross RW (1994) Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion . Biochemistry (Mosc) 33:5805–5812
https://doi.org/10.1021/bi00185a019
32 Goodenowe DB, Cook LL, Liu Jet al. (2007) Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer’s disease and dementia . J Lipid Res 48:2485–2498.
https://doi.org/10.1194/jlr.P700023-JLR200
33 Graessler J, Schwudke D, Schwarz PEHet al. (2009) Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients . PLoS ONE 4:e6261.
https://doi.org/10.1371/journal.pone.0006261
34 Grimm MOW, Kuchenbecker J, Rothhaar TLet al. (2011) Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphatesynthase by amyloid precursor protein processing and is affected in Alzheimer’s disease: dysregulation of plasmalogen synthesis in AD . J Neurochem 116:916–925.
https://doi.org/10.1111/j.1471-4159.2010.07070.x
35 Hajra AK, Das AK (1996) Lipid biosynthesis in peroxisomesa . Ann NY Acad Sci 804:129–141
https://doi.org/10.1111/j.1749-6632.1996.tb18613.x
36 Han X (2005) Lipid alterations in the earliest clinically recognizable stage of Alzheimer’s disease: implication of the role of lipids in the pathogenesis of Alzheimer’s disease . Curr Alzheimer Res 2:65–77
https://doi.org/10.2174/1567205052772786
37 Han XL, Gross RW (1990) Plasmenylcholine and phosphatidylcholine membrane bilayers possess distinct conformational motifs . Biochemistry (Mosc) 29:4992–4996
https://doi.org/10.1021/bi00472a032
38 Han X, Holtzman DM, McKeel DW (2001) Plasmalogen deficiency in early Alzheimer’s disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry . J Neurochem 77:1168–1180
https://doi.org/10.1046/j.1471-4159.2001.00332.x
39 Hillebrand M, Gersting SW, Lotz-Havla ASet al. (2012) Identification of a new fatty acid synthesis-transport machinery at the peroxisomal membrane . J Biol Chem 287:210–221.
https://doi.org/10.1074/jbc.M111.272732
40 Hofer DC, Pessentheiner AR, Pelzmann HJet al. (2017) Critical role of the peroxisomal protein PEX16 in white adipocyte development and lipid homeostasis . Biochim Biophys Acta BBA Mol Cell Biol Lipids 1862:358–368.
https://doi.org/10.1016/j.bbalip.2016.12.009
41 Honsho M, Asaoku S, Fukumoto K, Fujiki Y (2013) Topogenesis and homeostasis of fatty acyl-CoA reductase 1 . J Biol Chem 288:34588–34598.
https://doi.org/10.1074/jbc.M113.498345
42 Hossain MS, Ifuku M, Take Set al. (2013) Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling . PLoS ONE 8:e83508.
https://doi.org/10.1371/journal.pone.0083508
43 Hossain MS, Mineno K, Katafuchi T (2016) Neuronal orphan G-Protein coupled receptor proteins mediate plasmalogensinduced activation of ERK and Akt signaling . PLOS ONE 11: e0150846.
https://doi.org/10.1371/journal.pone.0150846
44 Hua R, Cheng D, Coyaud Éet al. (2017) VAPs and ACBD5 tether peroxisomes to the ER for peroxisome maintenance and lipid homeostasis . J Cell Biol.
https://doi.org/10.1083/jcb.201608128
45 Huang JH, Park H, Iaconelli Jet al. (2016) Unbiased metabolite profiling of schizophrenia fibroblasts under stressful perturbations reveals dysregulation of plasmalogens and phosphatidylcholines . J Proteome Res.
https://doi.org/10.1021/acs.jproteome.6b00628
46 James PF, Lake AC, Hajra AKet al. (1997) An animal cell mutant with a deficiency in acyl/alkyl-dihydroxyacetone-phosphate reductase activity: effects on the biosynthesis of ether-linked and diacyl glycerolipids . J Biol Chem 272:23540–23546
https://doi.org/10.1074/jbc.272.38.23540
47 Jang JE, Park H-S, Yoo HJet al. (2017) Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis . Hepatology.
https://doi.org/10.1002/hep.29039
48 Khaselev N, Murphy RC (1999) Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation . Free Radic Biol Med 26:275–284
https://doi.org/10.1016/S0891-5849(98)00211-1
49 Komljenovic D, Sandhoff R, Teigler Aet al. (2009) Disruption of blood-testis barrier dynamics in ether-lipid-deficient mice . Cell Tissue Res 337:281–299.
https://doi.org/10.1007/s00441-009-0809-7
50 LaBelle EF, Hajra AK (1974) Purification and kinetic properties of acyl and alkyl dihydroxyacetone phosphate oxidoreductase . J Biol Chem 249:6936–6944
51 Lankinen M, Schwab U, Kolehmainen Met al. (2016) A healthy nordic diet alters the plasma lipidomic profile in adults with features of metabolic syndrome in a multicenter randomized dietary intervention . J Nutr 146:662–672.
https://doi.org/10.3945/jn.115.220459
52 Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues . Free Radic Biol Med 20:463–466
https://doi.org/10.1016/0891-5849(96)02051-5
53 Li Z, Agellon LB, Allen TMet al. (2006) The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis . Cell Metab 3:321–331.
https://doi.org/10.1016/j.cmet.2006.03.007
54 Lodhi IJ, Yin L, Jensen-Urstad APLet al. (2012) Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity . Cell Metab 16:189–201.
https://doi.org/10.1016/j.cmet.2012.06.013
55 Lodhi IJ, Wei X, Yin Let al. (2015) Peroxisomal lipid synthesis regulates inflammation by sustaining neutrophil membrane phospholipid composition and viability . Cell Metab 21:51–64.
https://doi.org/10.1016/j.cmet.2014.12.002
56 Lohner K (1996) Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes ? Chem Phys Lipids 81:167–184
https://doi.org/10.1016/0009-3084(96)02580-7
57 Luoma AM, Kuo F, Cakici Oet al. (2015) Plasmalogen phospholipids protect internodal myelin from oxidative damage . Free Radic Biol Med 84:296–310.
https://doi.org/10.1016/j.freeradbiomed.2015.03.012
58 Maeba R, Sawada Y, Shimasaki Het al. (2002) Ethanolamine plasmalogens protect cholesterol-rich liposomal membranes from oxidation caused by free radicals . Chem Phys Lipids 120:145–151
https://doi.org/10.1016/S0009-3084(02)00101-9
59 Marrink S-J, Mark AE (2004) Molecular view of hexagonal phase formation in phospholipid membranes . Biophys J 87:3894–3900.
https://doi.org/10.1529/biophysj.104.048710
60 McIntyre TM, Pontsler AV, Silva ARet al. (2003) Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist . Proc Natl Acad Sci 100:131–136
https://doi.org/10.1073/pnas.0135855100
61 Morand OH, Zoeller RA, Raetz CR (1988) Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation . J Biol Chem 263:11597–11606
62 Motley AM, Hettema EH, Hogenhout EMet al. (1997) Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor . Nat Genet 15:377–380
https://doi.org/10.1038/ng0497-377
63 Mueller HW, O’Flaherty JT, Wykle RL (1982) Ether lipid content and fatty acid distribution in rabbit polymorphonuclear neutrophil phospholipids . Lipids 17:72–77
https://doi.org/10.1007/BF02535178
64 Mueller HW, O’Flaherty JT, Greene DGet al. (1984) 1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species . J Lipid Res 25:383–388
65 Munn NJ (2003) Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport . J Lipid Res 44:182–192.
https://doi.org/10.1194/jlr.M200363-JLR200
66 Nagan N, Zoeller RA (2001) Plasmalogens: biosynthesis and functions . Prog Lipid Res 40:199–299
https://doi.org/10.1016/S0163-7827(01)00003-0
67 Orešič M, Simell S, Sysi-Aho Met al. (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes .J Exp Med 205:2975–2984.
https://doi.org/10.1084/jem.20081800
68 Paltauf F (1994) Ether lipids in biomembranes . Chem Phys Lipids 74:101–139
https://doi.org/10.1016/0009-3084(94)90054-X
69 Piano V, Benjamin DI, Valente Set al. (2015) Discovery of inhibitors for the ether lipid-generating enzyme AGPS as anti-cancer agents . ACS ChemBiol 10:2589–2597.
https://doi.org/10.1021/acschembio.5b00466
70 Pietiläinen KH, Sysi-Aho M, Rissanen Aet al. (2007) Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects—a monozygotic twin study . PLoS ONE 2:e218.
https://doi.org/10.1371/journal.pone.0000218
71 Pietiläinen KH, Róg T, Seppänen-Laakso Tet al. (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans . PLoS Biol 9:e1000623.
https://doi.org/10.1371/journal.pbio.1000623
72 Pike LJ, Han X, Chung K-N, Gross RW (2002) Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of Caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis† . Biochemistry (Mosc) 41:2075–2088.
https://doi.org/10.1021/bi0156557
73 Purdue PE (1997) Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTSZ . Nat Genet 15:381
https://doi.org/10.1038/ng0497-381
74 Puri P, Wiest MM, Cheung Oet al. (2009) The plasma lipidomic signature of nonalcoholic steatohepatitis . Hepatology 50:1827–1838
https://doi.org/10.1002/hep.23229
75 Rasmiena AA, Barlow CK, Stefanovic Net al. (2015) Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice . Atherosclerosis 243:598–608.
https://doi.org/10.1016/j.atherosclerosis.2015.10.096
76 Reiss D, Beyer K, Engelmann B (1997) Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro . Biochem J 323:807–814
https://doi.org/10.1042/bj3230807
77 Rodemer C, Thai T-P, Brugger Bet al. (2003) Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice . Hum Mol Genet 12:1881–1895.
https://doi.org/10.1093/hmg/ddg191
78 RooS DS, Choppin PW (1984) Tumorigenicity of cell lines with altered lipid composition . Proc Natl Acad Sci 81:7622–7626
https://doi.org/10.1073/pnas.81.23.7622
79 Skaff O, Pattison DI, Davies MJ (2008) The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study† . Biochemistry (Mosc) 47:8237–8245.
https://doi.org/10.1021/bi800786q
80 Snyder F (1999) The ether lipid trail: a historical perspective . Biochim Biophys Acta BBA Mol Cell Biol Lipids 1436:265–278
https://doi.org/10.1016/S0005-2760(98)00172-6
81 Snyder F, Wood R (1969) Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues . Cancer Res 29:251–257
82 Snyder F, Cress EA, Stephens N (1966) An unidentified lipid prevalent in tumors . Lipids 1:381–386
https://doi.org/10.1007/BF02532540
83 Snyder F, Blank ML, Morris HP (1969) Occurrence and nature of O-alkyl and O-alk-1-enyl moieties of glycerol in lipids of Morris transplanted hepatomas and normal rat liver . Biochim Biophys Acta BBA Lipids Lipid Metab 176:502–510
https://doi.org/10.1016/0005-2760(69)90217-3
84 Steinberg SJ, Raymond GV, Braverman NE, Moser AB (2012) Peroxisome biogenesis disorders, Zellweger syndrome spectrum.
85 Teigler A, Komljenovic D, Draguhn Aet al. (2009) Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum . Hum Mol Genet 18:1897–1908.
https://doi.org/10.1093/hmg/ddp110
86 Tessier C, Sweers K, Frajerman Aet al. (2016) Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations . Transl Psychiatry 6:e906.
https://doi.org/10.1038/tp.2016.142
87 Thukkani AK, Hsu F-F, Crowley JRet al. (2002) Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: Production Of The Chemoattractant, 2-Chlorohexadecanal . J Biol Chem 277:3842–3849.
https://doi.org/10.1074/jbc.M109489200
88 Tsukahara T, Tsukahara R, Yasuda Set al. (2006) Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferatoractivated receptor . J Biol Chem 281:3398–3407.
https://doi.org/10.1074/jbc.M510843200
89 Tulodziecka K, Diaz-Rohrer BB, Farley MMet al. (2016) Remodeling of the postsynaptic plasma membrane during neural development . Mol Biol Cell 27:3480–3489
https://doi.org/10.1091/mbc.E16-06-0420
90 Volmer R, van der Ploeg K, Ron D (2013) Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains . Proc Natl Acad Sci 110:4628–4633.
https://doi.org/10.1073/pnas.1217611110
91 Wang G, Wang T (2010) The role of plasmalogen in the oxidative stability of neutral lipids and phospholipids . J Agric Food Chem 58:2554–2561.
https://doi.org/10.1021/jf903906e
92 White AL, Modaff P, Holland-Morris F, Pauli RM (2003) Natural history of rhizomelic chondrodysplasia punctata . Am J Med Genet 118A:332–342.
https://doi.org/10.1002/ajmg.a.20009
93 Wood P, mankidy R, Ritchie Set al. (2010) Circulating plasmalogen levels and Alzheimer disease assessment scale-cognitive scores in Alzheimer patients . J Psychiatry Neurosci 35:59–62.
https://doi.org/10.1503/jpn.090059
94 Wood PL, Locke VA, Herling Pet al. (2016) Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer’s disease (LOAD) . BBA Clin 5:25–28.
https://doi.org/10.1016/j.bbacli.2015.11.004
95 Yamashita S, Kanno S, Nakagawa Ket al. (2015a) Extrinsic plasmalogens suppress neuronal apoptosis in mouse neuroblastoma Neuro-2A cells: importance of plasmalogen molecular species . RSC Adv 5:61012–61020.
https://doi.org/10.1039/C5RA00632E
96 Yamashita S, Kiko T, Fujiwara Het al. (2015b) Alterations in the levels of amyloid-β, phospholipid hydroperoxide, and plasmalogen in the blood of patients with Alzheimer’s disease: possible interactions between amyloid-β and these lipids . J Alzheimers Dis 50:527–537.
https://doi.org/10.3233/JAD-150640
97 Yen C-LE, Mar M, Zeisel SH (1999) Choline deficiency-induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase . FASEB J 13:135–142
https://doi.org/10.1096/fasebj.13.1.135
98 Zhang C, Baker DL, Yasuda Set al. (2004) Lysophosphatidic acid induces neointima formation through PPARγ activation . J Exp Med 199:763–774.
https://doi.org/10.1084/jem.20031619
99 Zoeller RA, Morand OH, Raetz CR (1988) A possible role for plasmalogens in protecting animal cells against photosensitized killing . J Biol Chem 263:11590–11596
[1] Mona Teng, Stanley Zhou, Changmeng Cai, Mathieu Lupien, Housheng Hansen He. Pioneer of prostate cancer: past, present and the future of FOXA1[J]. Protein Cell, 2021, 12(1): 29-38.
[2] Henry Y. Jiang, Sara Najmeh, Guy Martel, Elyse MacFadden-Murphy, Raquel Farias, Paul Savage, Arielle Leone, Lucie Roussel, Jonathan Cools-Lartigue, Stephen Gowing, Julie Berube, Betty Giannias, France Bourdeau, Carlos H. F. Chan, Jonathan D. Spicer, Rebecca McClure, Morag Park, Simon Rousseau, Lorenzo E. Ferri. Activation of the pattern recognition receptor NOD1 augments colon cancer metastasis[J]. Protein Cell, 2020, 11(3): 187-201.
[3] Ruyi Xu, Yi Li, Yang Liu, Jianwei Qu, Wen Cao, Enfan Zhang, Jingsong He, Zhen Cai. How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?[J]. Protein Cell, 2020, 11(12): 881-893.
[4] Weiwei Jiang, Fangfang Cai, Huangru Xu, Yanyan Lu, Jia Chen, Jia Liu, Nini Cao, Xiangyu Zhang, Xiao Chen, Qilai Huang, Hongqin Zhuang, Zi-Chun Hua. Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner[J]. Protein Cell, 2020, 11(11): 825-845.
[5] Fenjie Li, Junjun Ding. Sialylation is involved in cell fate decision during development, reprogramming and cancer progression[J]. Protein Cell, 2019, 10(8): 550-565.
[6] Wei Shao, Shasha Li, Lu Li, Kequan Lin, Xinhong Liu, Haiyan Wang, Huili Wang, Dong Wang. Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun[J]. Protein Cell, 2019, 10(3): 161-177.
[7] Boyi Zhang, Fei Chen, Qixia Xu, Liu Han, Jiaqian Xu, Libin Gao, Xiaochen Sun, Yiwen Li, Yan Li, Min Qian, Yu Sun. Revisiting ovarian cancer microenvironment: a friend or a foe?[J]. Protein Cell, 2018, 9(8): 674-692.
[8] Yelei Guo, Kaichao Feng, Yao Wang, Weidong Han. Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment[J]. Protein Cell, 2018, 9(6): 516-526.
[9] Jia Yang, Jun Yu. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get[J]. Protein Cell, 2018, 9(5): 474-487.
[10] Xiao-xiao Xu, Han Wan, Li Nie, Tong Shao, Li-xin Xiang, Jian-zhong Shao. RIG-I: a multifunctional protein beyond a pattern recognition receptor[J]. Protein Cell, 2018, 9(3): 246-253.
[11] Nicole M. Anderson, Patrick Mucka, Joseph G. Kern, Hui Feng. The emerging role and targetability of the TCA cycle in cancer metabolism[J]. Protein Cell, 2018, 9(2): 216-237.
[12] Yanjing Song, Chuan Tong, Yao Wang, Yunhe Gao, Hanren Dai, Yelei Guo, Xudong Zhao, Yi Wang, Zizheng Wang, Weidong Han, Lin Chen. Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo[J]. Protein Cell, 2018, 9(10): 867-878.
[13] Xiaowei Chen, Zhen Fan, Warren McGee, Mengmeng Chen, Ruirui Kong, Pushuai Wen, Tengfei Xiao, Xiaomin Chen, Jianghong Liu, Li Zhu, Runsheng Chen, Jane Y. Wu. TDP-43 regulates cancer-associated microRNAs[J]. Protein Cell, 2018, 9(10): 848-866.
[14] Kaichao Feng, Yang Liu, Yelei Guo, Jingdan Qiu, Zhiqiang Wu, Hanren Dai, Qingming Yang, Yao Wang, Weidong Han. Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers[J]. Protein Cell, 2018, 9(10): 838-847.
[15] Kyoji Tsuchikama, Zhiqiang An. Antibody-drug conjugates: recent advances in conjugation and linker chemistries[J]. Protein Cell, 2018, 9(1): 33-46.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed